Expression of PD-L1 on the surface of DCs interacts with CD8+ T cells to inhibit their activation, while the reduction of IL-12 leads to the blockade of hepatic stellate cell activation and ECM release, thereby reducing liver fibrosis (177). This evidence concerns the gene CD8A and Hepatic fibrosis.